|
KR20080024426A
|
|
A stabilized hyaluronic acid derivative composition
|
|
WO2007044976A2
|
|
Improved testosterone gel and method of use
|
|
AU2006262195A1
|
|
Dronabinol treatment for migraines
|
|
CN101175403A
|
|
Dronabinol treatment of delayed chemotherapy-induced nausea and vomiting
|
|
BRPI0610364A2
|
|
dronabinol treatment of chemotherapy-induced delayed nausea and vomiting
|
|
CN101217874A
|
|
Method of treating or preventing bone deterioration or osteoporosis
|
|
CA2599213A1
|
|
Dronabinol compositions and methods of using same
|
|
EP1696929A2
|
|
Delta-9-thc compositions and methods for treating symptoms associated with multiple sclerosis
|
|
CN101043890A
|
|
Delta-9-thc for treating symptoms associated with multiple sclerosis
|
|
AU2003277388A1
|
|
Method for treating erectile dysfunction and increasing libido in men
|
|
MXPA04008988A
|
|
Tissue monitoring system for intravascular infusion.
|
|
IL163981D0
|
|
Androgen pharmaceutical composition and method fortreating depression
|
|
KR20040076943A
|
|
Implements of cupping glass with low frequency
|
|
CA2498267A1
|
|
Method for treating erectile dysfunction and increasing libido in men
|
|
IL154692D0
|
|
Method of treating erectile dysfunction and increasing libido in men
|
|
CA2497686A1
|
|
Method of increasing testosterone and related steroid concentrations in women
|
|
AU8536701A
|
|
Method of increasing testosterone and related steroid concentrations in women
|
|
US6503894B1
|
|
Pharmaceutical composition and method for treating hypogonadism
|
|
US6747058B1
|
|
Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor
|
|
KR20010093538A
|
|
A Process for Preparing Cisapride
|
